CATIONIC NANOSTRUCTURED LIPID CARRIERS: OPTIMIZATION OF ZETA POTENTIAL AND EVALUATION by BAIG, MIRZA SALMAN & SIDDIQUI, AQUIL-UR-RAHIM
 
 




MIRZA SALMAN BAIG1,2*, AQUIL-UR-RAHIM SIDDIQUI3 
1Y. B. Chavan College of Pharmacy, Dr Babasaheb Ambedkar Marathwada University, Aurangabad, Maharashtra, India, 2Anjuman-i-Islam’s 
Kalsekar Technical Campus, School of Pharmacy, Affiliated to University of Mumbai, Maharashtra, India, 3
Received: 20 Mar 2020, Revised and Accepted: 15 Apr 2020 
Shri Bhagwan College of 
Pharmacy, Dr Babasaheb Ambedkar Marathwada University, Aurangabad, Maharashtra, India 
Email: mirzasalman.pharma@gmail.com 
ABSTRACT 
Objective: To fabricate, optimize and evaluate, Lipid-based cationic nanoparticulate dispersed system to improve the bio-adhesion property for 
ophthalmic use. 
Methods: Lipid-based cationic nanoparticulate dispersed system was fabricated by melt emulsification ultrasonication method and Box-Behnken 
design was utilized for optimization of formulation through the Design-Expert® program. The concentration of stabilizer, liquid lipid and 
Cetyltrimethylammonium Bromide (CTAB) was selected as variables (factors) while particle size, zeta potential and polydispersity index (PDI) were 
selected as a response for optimization purpose. Characterization of particle properties was performed using Transmission Electron Microscopy 
(TEM), Photon correlation spectroscopy (PCS). Fourier-transform infrared spectroscopy (FT-IR) was performed to study chemical interaction 
among ingredients. Rhodamine B entrapped CNLC formulation was used to study the interaction of NLC and CNLC on a three-dimensional and two-
dimensional ocular tissue model for cell uptake and penetration properties. 
Results: Cationic nanostructured lipid carrier system was successfully fabricated by melt emulsification ultrasonication method. Characterization of 
nanoparticulate system using PCS revealed particle size in the range of 113.1 to 274.2 nm, PDI in a range of 0.147 to 0.280, while zeta potential in 
the range of 7.2 to 49.8 mV. The validation of statistical design suggested that it was suitable for navigation of design space. TEM imaging confirmed 
the results of PCS characterization. FT-IR study suggested a minimal chemical interaction among ingredients in CNLC. Confocal laser microscopic 
imaging for the interaction of NLC and CNLC on a three-dimensional and two-dimensional ocular tissue model revealed good penetration and bio-
adhesion properties. 
Conclusion: The fabricated Cationic nanostructured lipid carrier system was found to be the potential ophthalmic novel drug delivery system with 
good bio-adhesion and penetration properties.  
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INTRODUCTION 
Topical instillation of the eye drops is a popular method for 
ophthalmic medicines. But this method suffers many challenges 
because of anatomy and physiology of eye. Physiological factors like 
the blinking of eyes and tear turn over results in spillage of medicine 
[1]. Also, there are other barriers like cornea, which limit the 
permeation of the medicine [2]. The volume of the cul-de-sac is very 
less hence a large volume of medicines can’t be instilled. Frequent 
instillation of the drug is a tedious task with low patient compliance 
[3]. All these reasons result in the poor therapeutic efficacy of 
topically administered ophthalmic medicine. Hence, there was a 
need of novel ophthalmic drug carrier system which could improve 
the efficacy of medicine through topical rout [4-6]  
Nanostructured lipid carrier (NLC) are lipid-based nanoparticulate 
system prepared by adding liquid lipids along with solid lipid [7]. 
These colloidal lipid carriers are bio-degradable and show good 
entrapment efficiency compare to solid lipid nanoparticles (SLN). 
Cationic nanostructured lipid carrier (CNLC) are functional 
nanostructured lipid carriers which possesses positive charge on 
its surface [8]. Positive charge on its surface provide good 
adherence property to body cells while liquid lipid is incorporated 
to enhance drug loading capacity of lipid carrier [9]. Small size of 
particles in the nanometric range could make it permeable to the 
desired site for action. These properties of CNLC makes it a 
suitable candidate as the novel colloidal carrier for targeted drug 
delivery, especially to ocular tissue [10]. 
The purpose of the current study was to know the effect of various 
ingredients of CNLC like the concentration of stabilizer, liquid lipid, 
surfactant, type of liquid lipid on particle properties like particle 
size, zeta potential and polydispersity index (PDI). Different types of 
liquid lipids were explored like Imwitor, Miglyol and Labrafac to 
study its effect on properties of nanostructured lipid carriers. The 
CNLC formulation was prepared using the melt-emulsification 
ultrasonication method. The CNLC containing the labrafac were 
further exploited and investigated to develop optimum CNLC 
formulation. Cetyltrimethylammonium Bromide (CTAB) was added 
to induce a positive charge on nanoparticles [11]. 
MATERIALS AND METHODS 
Materials  
Labrafac PG, Gelucire 50/13 and Compritol 888 atomized, were 
provided by Gattefossé. Miglyol® 812 N and Imwitor® 948 were a 
kind gift from IOI Oleo GmbH, Germany. Cetyltrimethylammonium 
Bromide (CTAB), Hoechst stain solution and Rhodamine B octadecyl 
ester perchlorate were procured through Sigma-Aldrich. While other 
reagents were of the analytical grade. 
Methods 
Preparation of NLC and CNLC 
Nanostructured lipid carriers (NLC) and cationic nanostructured 
lipid carriers (CNLC) were prepared using the melt-emulsification 
ultrasonic homogenization method as shown in fig. 1 [12, 13]. 
Stabilizer, Solid lipid and Liquid Lipid were heated in glass vial then 
Rhodamine B stain was added to molten lipid mix (80 °C), finally 
pre-heated distilled water was added to molten lipid phase which 
was then homogenized using a vortex mixer. This coarse dispersion 
was subjected to probe ultra-sonication and allowed to cool at room 
temperature to obtain colloid. 
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Fig. 1: Method of preparation for CNLC 
 
Photon correlation spectroscopy (PCS) 
All the sample were diluted 500 times before measurement. Malvern 
zeta sizer was employed for Photon correlation spectroscopy [14, 
15]. All the readings were noted at 25 °C. 
Entrapment of rhodamine-B 
Ultracentrifuge filtration method was used for determining percent 
entrapment efficiency. Centrifugation was done at 3000 G for 20 
min. Rhodamine B loaded NLC/CNLC was filtered through 10K 
molecular weight cut off ultrafilter. The filtrate was analysed using 
UV absorbance technique for any traces of Rhodamine-B [16]. 
Transmission electron microscopy (TEM) 
Distilled water was added to the sample dilute it up to 100 times, 
then spreading was done over the copper grid. Sample was air-dried 
for one hour before imaging. The instrument JEM-1230 JEOL, Japan 
was used for TEM imaging. The method was used to confirm the 
shape and size of CNLC formulation [6, 8] 
FT-IR spectroscopy 
Infra-red spectral analysis of CNLC and physical mixture were 
performed using Nicolet iS50, Thermo-Fisher FT-IR spectrometer. 
CNLC formulation or physical mixture was mixed with acetone then 
spread on calcium fluoride disc. After evaporation of acetone, a thin 
film so obtained was used to obtain FT-IR [17]. The spectra were 
collected and processed through OMNIC software. 
Tissue culture study 
Method of preparation of tissue model 
Porcine eyes conjunctival membrane was removed and digested by 
enzyme collagenase and dispase. The cell culture was prepared in 
Dulbecco’s modified eagle’s medium containing glucose along with 5 
percent carbon-di-oxide at 37 °C. Also, one percent L-glutamine, ten 
percent foetal bovine serum, along with one percent antibiotics 
combination of streptomycin and penicillin was added. The 3D 
conjunctival tissue model was developed using collagen hydrogels 
(Fisher Scientific, UK) by incorporating fibroblast cells in it at a density 
of 80,000 cells/100 µl gel. The supplementary culture medium was 
added during the preparation of the gel-cell model [18, 19]. 
Internalization of NLC and CNLC in tissue culture models 
To study the effect of rhodamine B loaded NLC-B (without CTAB) 
and optimum CNLC (with CTAB) formulations on cell internalization 
capacity, the fibroblast cells were cultured by the above-mentioned 
method. Cells were incubated with Hoechst reagent for 15 min to 
stain nuclei with blue colour, then fibroblast cells were incubated 
separately with 5 percent NLC and 5 percent CNLC formulations into 
the culture medium for 30 min. The formulation containing culture 
medium was removed and fresh culture medium was added before 
cell imaging using a confocal microscope (Olympus) [10, 19] 
 
 
Fig. 2: Graph showing particle-size (a) polydispersity-index (b) 
and zeta-potential (c) for various NLC formulations (n=3) 
 
Permeation of CNLC in three-dimensional tissue-model  
Collagen-based gel was prepared. The fibroblast cells incubated in 
gel after incubation for around 2 d until the cells elongate. Ten 
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percent of ‘rhodamine B loaded optimum CNLC’ prepared in the 
culture medium. This was added over the gel-based model after 
removing old culture medium, then incubated for an hour, media 
before imaging. 3D imaging was done by laser confocal-microscope 
to study penetration of CNLC across the gel-cell model [13, 19, 20] 
RESULTS AND DISCUSSION 
Effect of various liquid lipid on properties of NLC 
The NLC contain liquid lipid, unlike the Solid Lipid Nanoparticles 
(SLN). There are profound effects of liquid-lipid on properties of 
nanoparticles, especially particle size, PDI and entrapment efficiency 
[6, 14, 21]. The effect of different liquid lipids like Miglyol, Labrafac 
and Imwitor have been studied for mentioned properties of NLC and 
CNLC formulations. The decrease in particle size and PDI was 
observed after the addition of liquid lipid because it caused the 
lowering of consistency of molten lipid mixture during formulation 
processes. Low consistency of lipid phase provides more time to 
internal phase globules to acquire uniform spherical shape before it 
solidifies; hence a low PDI was observed. Particle size and PDI for 
Labrafac containing NLC-B was found to be least (fig. 2 a-b) among 
other NLC formulations containing miglyol and imwitor. While zeta 
potential for NLC-B was found to be highest among other types of 
NLC formulations, which are attributed to the miscibility of labrafac 
with solid lipid (compritol). 
Effect of CTAB concentration on properties of CNLC 
When the concentration of CTAB was varied from 2.5 to 7.5 mg/ml 
in CNLC, an increment in zeta potential was observed from 42 to 
46.4 mV as shown in fig. 3. CTAB is a cationic surfactant which 
makes the surface of nanoparticles positively charged [10, 22]. Also, 
a slight increase in particle-size was observed on the increment of 
CTAB concentration, probably because of the adsorption of CTAB at 
the interphase of the solid (nanoparticles) and liquid medium. 
  
Table 1: Formulae for various NLC and CNLC formulations 
 Formulation 
Ingredients(per ml) NLC-A NLC-B NLC-C CNLC (2.5) CNLC(5) CNLC (7.5) 
Compritol 888 ATO(mg) 20 20 20 20 20 20 
Gelucire 50/13(mg) 30 30 30 30 30 30 
Miglyol® 812 N(µl) 10 -- -- -- -- -- 
Labrafac PG ®(µl) -- 10 -- 10 10 10 
Imwitor® 948(µl) -- -- 10 -- -- -- 
CTAB(mg) -- -- -- 2.5 5.0 7.5 
 
 
Fig. 3: Graph showing particle size and zeta potential of various CNLC formulations (n=3) 
 
Table 2: Factors and responses for box-behnken experimental design and optimization 
 Name Unit Factor level in actual 
   Low  Medium  High  
Factor      
X Gelucire 1 mg/ml 10 20 30 
X Labrafac 2 µl/ml 10 15 20 
X CTAB 3 mg/ml 0.5 2.75 5 
Response   Constraints  
Y Particle size 1 nm Reduce 
Y Polydispersity Index (PDI) 2  Reduce 
Y Zeta Potential 3 mV Augment  
 
Optimization of CNLC  
It was found through studies that concentration of CTAB up to 5 
mg/ml was enough to induce positive zeta potential up to 44.6 mV. 
Hence, a range of CTAB was selected from 0.5 to 5 mg/ml in the 
CNLC formulation. Optimization constraints for various independent 
variables are mentioned in table 1.  
Design-Expert® software was utilized for optimization studies [13, 23]. 
The significant factors identified for optimization were concentration of 
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stabilizer, liquid lipid and CTAB. However, responses observed were 
particle size, zeta potential and PDI. Total 17 formulation runs were 
prepared based on the combination of significant independent variables 
as provided by software and mentioned in table 2. The Box Behnken 
statistical method was employed for experimental design, because a few 
numbers of formulation were required for optimization. Experimental 
values for responses were fed in software for calculation and analysis 
table 3. The equations which were extracted from software in terms of 
actual factors could be utilized for making predictions of response for 
different levels of each factor. 
 



























X X1 X2 Y3 Y1 Y2 Y3 Y1 Y2 3 
1 12 10 10 2.75 165.6 0.263 38.9 193.26 0.278272 38.20 
2 11 30 10 2.75 159.4 0.28 19.5 178.46 0.247022 20.92 
3 17 10 20 2.75 274.2 0.147 34.5 297.23 0.180272 33.82 
4 10 30 20 2.75 113.1 0.164 13.4 127.53 0.149022 16.55 
5 9 10 15 0.5 237.7 0.238 14.6 229.26 0.219647 21.26 
6 15 30 15 0.5 129.8 0.165 7.2 129.96 0.188397 3.98 
7 6 10 15 5 262.5 0.271 49.8 261.23 0.238897 50.76 
8 5 30 15 5 168.7 0.185 28.6 176.03 0.207647 33.48 
9 13 20 10 0.5 152.3 0.25 9.1 155.99 0.253022 14.81 
10 7 20 20 0.5 194.9 0.178 9.3 203.22 0.155022 10.43 
11 8 20 10 5 219.2 0.27 43.5 215.72 0.272272 44.31 
12 1 20 20 5 220.4 0.182 36.3 221.54 0.174272 39.93 
13 14 20 15 2.75 237.4 0.196 39.6 199.12 0.213647 27.37 
14 4 20 15 2.75 193.4 0.208 27.7 199.12 0.213647 27.37 
15 3 20 15 2.75 217.6 0.22 31.4 199.12 0.213647 27.37 
16 2 20 15 2.75 197.2 0.211 30.2 199.12 0.213647 27.37 
17 16 20 15 2.75 241.6 0.204 31.7 199.12 0.213647 27.37 
 
 
Fig. 4: Three-dimensional response surface graph showing the effect of significant independent variables on particle-size (a), 
polydispersity-index (b) and zeta-potential (c) of CNLC formulations 
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Particle size (Y1
Size of nanoparticles range from 113.1 to 274.2 nm. The effect of 
stabilizer (gelucire) and liquid lipid (labrafac) concentration was 
found to be significant as revealed in fig. 4a. Following equation 
concerning actual factors represent an effect on particle size. 
) 





Polydispersity index (PDI) range from 0.147 to 0.280. The effect of 
stabilizer (gelucire) and liquid lipid (labrafac) was found to be 
significant as revealed in fig. 4b. Increase in liquid lipid 
concentration reduces PDI. Following equation concerning actual 
factors represent an effect on PDI. 
) 




Zeta potential range from 7.2 to 49.8 mV. The effect of stabilizer 
(gelucire) and CTAB was found to be significant as revealed in fig. 4c. 
Increase in CTAB concentration increases zeta potential. Following 
equation concerning actual factors represent an effect on zeta 
potential. 
)  
Y3 = 33.1803–0.8638 X1–4375 X2+6.5555 X
Experimental design validation of the model showed good results. 
Experimental values of dependent variables for those formulations 
were fed in software for processing. Table 4 shows the report of the 
model fit summary for Box-Behnken statistical experimental design. 
The best fit statistical model for particle size was two-factor 
interaction (2FI) and the best fit statistical model for PDI and zeta 
potential was linear, while for all the factors, the focus was on the 
model, maximizing the adjusted R² and the predicted R².  
3 
Fig. 5 revealed the scatter plot for experimental response values 
plotted against predicted values for dependent variables. Values of 
adjusted R2 and predicted R2
  
 was close enough so that a difference of 
not more than 0.2 was observed for all the three dependent 
variables. The run and sequence residual graphs are scatter plot in 
which externally studentized residuals were plotted against the run 
number. This represents the randomized run order concerning the 
time of making formulation, as revealed in fig. 6. Validation of 
statistical model because of the mentioned reasons make it fit to 
navigate the design-space of dependent variables. 
 
Fig. 5: Graph showing predicted vs actual values for particle-size (a), polydispersity-index (b) and zeta-potential (c) 
 
FT-IR spectroscopy 
Infrared spectrometry is a tool to study the interaction among the 
ingredients of nanoparticles [17]. Fig. 7 revealed FT-IR of optimum 
CNLC and physical mixture of all its ingredients in a similar 
proportion. A strong peak was observed at 3100 cm−1 in both the 
spectra because of the hydroxyl-OH stretching. Also, a peak near 
1650 cm−1 in both the spectra was observed because of C=O 
functional group stretching. FT-IR study suggest the chemical 
stability of ingredients in CNLC with minimal interaction. 
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Fig. 7: FT-IR graph for optimum CNLC formulation and physical mixture of its ingredients 
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Entrapment of rhodamine-B 
10 µg/ml of rhodamine was added to the lipid phase of NLC/CNLC 
during its preparation. A 100 % of entrapment was observed as no 
trace of rhodamine was observed in the filtrate, when filtered by 
ultracentrifuge filtration technique.  
Transmission electron microscopy (TEM) 
Transmission electron microscopy was performed to investigate 
particulate morphology. TEM image of optimum CNLC in fig. 8 
revealed spherical shape particles with small particle size (~ 200 
nm). Results of particle size found to agree with results of 
hydrodynamic diameter of nanoparticles, investigated by PCS 
technique. Turbid background was because of molecular level 
dispersion of gelucire in the medium.  
Cellular uptake 
Comparison rhodamine loaded nanoparticles formulation with CTAB 
(optimum CNLC) and without CTAB (NLC) was done to study its 
effect on cell uptake. Confocal laser microscopy used to study the 
threshold of nanoparticles uptake for both the formulations. Fig. 9a 
and 9b revealed that there was a profound difference in 
internalization with high uptake for CLNC while low cell uptake for 
NLC. High cellular uptake of optimum CNLC was attributed to bio-
adhesion of positively charged nanoparticles to negatively charged 
cell membrane because of electrostatic attraction [10]. Fig. 9c shows 
permeation of rhodamine entrapped CNLC by microscopic focus 
stacking through a three-dimensional conjunctival tissue model, 
which was prepared using collagen. A good permeation of the 
optimized CNLC was observed through the ocular tissue model. 
 
 
Fig. 8: Transmission electron microscopy (TEM) image for 
rhodamine optimum CNLC formulation 
 
 
Fig. 9: Image showing, cellular uptake (indicated with white arrow) of rhodamine loaded NLC-B formulation by conjunctival fibroblast 2D 
cell model (a), cellular uptake of rhodamine loaded optimum CNLC formulation by fibroblast 2D cell model (b) and an image showing 3D 
collagen gel permeation of rhodamine loaded optimum CNLC formulation (c) 
 
CONCLUSION 
A lipid-based colloidal nanoparticulate system CNLC was developed 
and compared with NLC for its cell interaction property. CNLC was 
found to be a better carrier system because it showed high cell 
uptake. The CNLC possesses of positive charge on its surface; hence 
it provides bio adhesion to the negatively charged membrane of 
conjunctiva fibroblast cells. Hence, we conclude CNLC holds 
potential as a novel ophthalmic drug-delivery system for 
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